{
    "Trade/Device Name(s)": [
        "GluNEO\u2122 Glucose Monitoring System",
        "GluNEO Professional Glucose Monitoring System",
        "GluNEO\u2122M Blood Glucose Monitoring System",
        "GluNEO\u2122M Professional Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K130181",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062058"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JQP",
        "JJX"
    ],
    "Summary Letter Date": "July 31, 2013",
    "Summary Letter Received Date": "July 2, 2013",
    "Submission Date": "June 24, 2013",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660",
        "21CFR862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single (specified) analyte controls",
        "Calculator/data processing module for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GluNEO Meter",
        "GluNEO Professional Meter",
        "PC-based software GlucoDiary"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Quantitative glucose measurement",
        "In vitro diagnostic testing"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control",
        "Software",
        "Accessory",
        "Lancing device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for GluNEO and GluNEO Professional blood glucose monitoring systems for quantitative measurement of glucose in whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood (home use, single patient) and in capillary/venous whole blood (professional use, multiple-patient); used as an aid for monitoring diabetes control, not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}